Cite
HARVARD Citation
Burke, M. et al. (2018). Severe pegaspargase hypersensitivity reaction rates (grade ≥3) with intravenous infusion vs. intramuscular injection: analysis of 54, 280 doses administered to 16, 534 patients on children's oncology group (COG) clinical trials. Leukemia & lymphoma. 59 (7), pp. 1624-1633. [Online].